Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:560 (17 March), doi:10.1136/bmj.334.7593.560-b
| The first 100% of the full text of this article appears below. |
Evidence based recommendations for treating hand osteoarthritis have been published by the European League Against Rheumatism. A 21 strong international guideline development group, including 16 rheumatologists, searched databases for acceptable trials, finding 309 studies of treatment of hand osteoarthritis in humans.
The systematic search was followed by a Delphi exercise that negotiated 11 propositions involving 17 treatment modules. In general, the paucity of clinical trials meant that levels of evidence were low (expert committee reports or opinion) except for topical non-steroidal anti-inflammatory drugs (NSAIDs), topical capsaicin, low dose short duration oral NSAIDs, and, possibly, intra-articular corticosteroids for painful flares in the trapeziometacarpal joint.
The group highlighted eight areas for future research.